We use cookies to collect information, and enable our website to work properly. Please tell us whether you accept cookies by clicking the button below. If you decide not to accept cookies, our site may not work as expected and some information may not be available.
Click here for more information on cookies, including how to remove them.
GenQA has extensive experience in providing haematological neoplasm EQAs for the past 20 years. These EQAs cover the common chronic and acute disorders including ALL, AML, CML, CLL, MDS, MPD, myeloma and lymphoma. To meet the needs of our participants, a range of sample types (online images, fixed cells, FFPE slides and DNA) and techniques (karyotyping, FISH, array/NGS and DNA mutation status) are included. In addition, participants can expect a broad range of referral types and abnormailties to analyse and report reflecting routine clinical practice.
We work closely with our colleagues in UK NEQAS Leucocyte Immunophenotyping (UK NEQAS LI) to deliver EQAs where the expert knowledge from both GenQA and UK NEQAS LI is beneficial to the delivery of the assessments.
Summary Information:
Assess the quality of testing and reporting of a broad range of haematological neoplasms, using various sample types and/or online case scenarios.
Based on real clinical cases, using validated samples.
Various sample types provided and any suitable techniques used.
6 weeks to submit the results.
Submitted laboratory reports are assessed, by an expert scientific panel, using international guidelines/recommendations.
Each participant receives an Individual Laboratory report (ILR) and EQA summary report detailing general findings, a summary of methodologies used, common errors and benchmarking against other laboratories worldwide.
Offers:
Enrol in 3 accredited Haematological Neoplasms EQAs and get Classification of Haematological neoplasms variants EQA for free!
Acute Lymphoblastic Leukaemia (ALL) (HALL)
Analysis and interpretation of recurrent and non-recurrent abnormalities associated with acute lymphoblastic leukaemia: online G-banded analysis with supplementary tests as applicable and/or DNA for whole genome copy number changes and structural rearrangements.
Analysis and interpretation of recurrent and non-recurrent abnormalities associated with chronic lymphocytic leukaemia: online G-banded analysis with supplementary tests as applicable and/or fixed cell suspensions for interphase FISH studies and/or DNA for whole genome copy number changes and structural rearrangements.
Analysis and interpretation of recurrent and non-recurrent abnormalities associated with lymphoma: online G-banded analysis with supplementary tests as applicable and/or FFPE slides and/or fixed cell suspensions for interphase FISH studies.
Next Generation Sequencing (NGS) analysis for detection of clinically relevant structural changes, copy number changes and single nucleotide variants associated with Lymphoma. The lymphoma samples provided will be either diagnostic primary samples, or infiltrated staging samples (where primary samples are not available).
Analysis and interpretation of recurrent and non-recurrent abnormalities associated with myeloid disorders: online G-banded analysis with supplementary tests as applicable and/or DNA for whole genome copy number changes and structural rearrangements in MDS.
Analysis and interpretation of recurrent abnormalities associated with myeloma: online interphase FISH analysis with supplementary tests as applicable, and/or fixed cell suspensions for interphase FISH, or DNA for array or NGS studies.
NEWSLETTER SIGN UP